Related Experiment Videos
Monoclonal IgM: difficulties with correct measurement
X Bossuyt1, G Vranken, G Mariën
1Department of Laboratory Medicine, University Hospitals Leuven, Belgium. xavier.bossuyt@uz.kuleuven.ac.be
Annals of Clinical Biochemistry
|December 6, 2001
Summary
Nephelometric quantification of immunoglobulin M (IgM) paraproteins can yield inaccurate results. This study identified three cases where this method failed, highlighting potential diagnostic challenges.
Area of Science:
- Clinical Chemistry
- Immunology
- Diagnostic Laboratory Science
Background:
- Monoclonal immunoglobulin M (IgM) paraproteins are associated with various hematologic disorders.
- Accurate quantification of IgM is crucial for diagnosis, monitoring treatment response, and assessing prognosis.
- Nephelometry is a common method for quantifying proteins in serum, including IgM.
Purpose of the Study:
- To report instances of inaccurate IgM quantification using nephelometry.
- To highlight potential limitations of nephelometric assays in specific clinical scenarios involving monoclonal IgM.
Main Methods:
- Case series describing three patients with monoclonal IgM paraproteins.
- Analysis of IgM quantification results obtained via nephelometry.
- Comparison with alternative methods or clinical data to assess accuracy.
Main Results:
- Nephelometric IgM quantification produced inaccurate results for all three described monoclonal IgM paraproteins.
- Discrepancies suggest potential interference or assay limitations with these specific paraprotein types.
Conclusions:
- Nephelometry may not be reliable for quantifying all types of monoclonal IgM paraproteins.
- Clinical laboratories should be aware of these potential inaccuracies and consider confirmatory testing when necessary.
- Further investigation into assay interferences is warranted.